GGrantIndex
Sort

40,608 grants matching prostate cancer

Comparative Biomedical Scientist Training Program

$897,515
Robert Simpson · Division Of Basic Sciences - Nci · ZIG · FY2012 · CA

Identification of human tumor-associated antigens

$896,832
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM

$896,519
Mount Sinai Medical Center (Miami Beach) · U10 · FY2003 · CA

Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern

$896,463
Martin G Sanda · Emory University · U01 · FY2025 · CA

Enhancing Native American Participation in RT Trials

$896,038
Rapid City Regional Hospital · U56 · FY2003 · CA

(2/2) TUFCCC/HC Regional Comprehensive Cancer Health Disparity Partnership

$895,790
Olorunseun O Ogunwobi · Hunter College · U54 · FY2020 · CA

Dayton Clinical Oncology Program

$895,458
Dayton Clinical Oncology Program · U10 · FY2004 · CA

Leadership, Planning and Evaluation

$895,353
Caryn Lerman · University Of Southern California · P30 · FY2024 · CA

Nuclear Factor-kappaB in Ovarian Cancer

$895,338
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Pathomic Predictors of Prostate Cancer Progression

$895,176
Parag Kumar Mallick · Stanford University · R01 · FY2023 · CA

Development of PSMA -based recombinant protein vaccines

$895,094
Gerald P Donovan · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · CA

SUPPORT SERVICES FOR THE PLCO ETIOLOGIC & EARLY MARKER STUDIES(PLCO EEMS)

$894,589
Tom Riley · Information Management Services, Inc. · N02 · FY2017 · CA

IDENTIFICATION OF GENES AND GENETIC VARIANTS ASSOCIATED WITH POOR TREATMENT RESONSE IN PATIENT WITH PROSTATE CANCER

$894,557
University Of Utah · · FY2011 · Department of Defense

Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models

$894,521
Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer

$894,497
Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2020 · CA

INVESTIGATING THE MECHANISMS OF AFRICAN-AMERICAN PROSTATE CANCER

$894,355
Dana-Farber Cancer Institute, Inc. · · FY2014 · Department of the Army

Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)

$893,587
Linda S Cook · University Of Colorado Denver · UG1 · FY2025 · CA

Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities

$893,050
Craig M Crews · Yale University · R35 · FY2022 · CA

Biostatistics Resource

$892,675
Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2012 · CA

LTQ-Orbitrap XL for protein identification and biomarker discovery

$892,482
Leroy E Hood · Institute For Systems Biology · S10 · FY2009 · RR

Molecular prediction of myeloma in African Americans

$892,457
Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2022 · CA

Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

$892,391
Henry Ford Health System · N01 · FY2008 · CA

TARGETING RNA-BINDING PROTEIN HUR AS A NOVEL THERAPY FOR LETHAL PROSTATE CANCER.

$892,342
University Of Kansas Center For Research Inc · · FY2021 · Defense Health Agency

Pain Sensitivity and Unpleasantness in People with Alzheimer's Disease and Cancer

$892,065
Ronald L Cowan · University Of Tennessee Health Sci Ctr · R01 · FY2022 · AG

TARGETED APPROACH TO OVERCOMING TREATMENT RESISTANCE IN ADVANCED PROSTATE CANCER

$891,991
Georgia Southern University Research & Service Foundation Inc · · FY2011 · Department of Defense